“This deal wouldn’t require the Sacklers to pay back a dime from the profits they made. All of it would be funded by future sales of OxyContin... The very deadly and addictive drug that has ravaged communities across this country.' - Mass. AG Maura Healey
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Purdue Pharma seeks to halt opioid suits against company, SacklersOxyContin maker Purdue Pharma LP on Wednesday asked a U.S. bankruptcy judge to h...
Consulte Mais informação »
What's next for OxyContin maker Purdue PharmaOxyContin maker Purdue Pharma LP filed for bankruptcy protection after reaching ...
Consulte Mais informação »
Oxycontin maker Purdue begins bankruptcy in push to settle opioid lawsuitsOxyContin maker Purdue Pharma LP is expected in court on Tuesday to lay out its ...
Consulte Mais informação »
WeWork delays its IPO amid tepid investor interestWeWork is pushing back its public debut with investor confidence appearing to grow shaky in the office share company that had recently been valued at around $47 billion.
Consulte Mais informação »
France's Macron embraces high-risk diplomacy at EU's expenseJust as the United States is seeking less frosty ties with the new leaders of th...
Consulte Mais informação »
Iran's Khamenei rejects talks with United StatesIran will never hold one-on-one talks with the United States but could engage in...
Consulte Mais informação »